QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:MDAS

(MDAS) (MDAS) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free MDAS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$31.35
▼
$31.35
50-Day Range
N/A
52-Week Range
$17.00
▼
$31.35
Volume
N/A
Average Volume
1.79 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
MDAS stock logo

About (MDAS) Stock (NASDAQ:MDAS)

MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.

MDAS Stock News Headlines

April 17, 2024 | msn.com
Nigeria: Tenure Policy - NUC Management 'Ignores' Director's Retirement Notice
April 16, 2024 | msn.com
Govt to pay Shs7.5t in harmonised wage bill
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 16, 2024 | baystreet.ca
Ocean Power Technology Loses Ground on News
April 13, 2024 | msn.com
FG reveals revenue received from MDAs in February
April 12, 2024 | msn.com
MDAs remitted N835.7bn revenue to FG in February – Edun
April 11, 2024 | msn.com
Banks face Sh500bn hit on State’s single account shift
April 10, 2024 | msn.com
Tech-aided assessment: Tracker app empowers Nigerians to monitor ministers’ performances
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 10, 2024 | msn.com
Aig-Imoukhuede Foundation trains civil servants in leadership
April 8, 2024 | msn.com
FG’s policy thrust will birth $1trn economy for Nigeria — IMPI
April 8, 2024 | msn.com
FG Sets Up Committee To Promote Health Of Civil Servants
April 8, 2024 | msn.com
Countdown to ending era of commercial banks holding Kenyan taxpayers’ money
April 8, 2024 | msn.com
Solar eclipse 2024: Where to watch rare celestial event in Bay Area today
April 5, 2024 | msn.com
Don't Overrun Budgets for Projects - Finance Minister Appeals to MDAs
April 2, 2024 | msn.com
Ondo AG Ajulo unfolds eight-point reforms
April 2, 2024 | msn.com
NGO’s lament spate of insecurities in Kogi
April 2, 2024 | msn.com
MWAURA: How KK administration is planning to spur economic take-off
April 1, 2024 | msn.com
Treasury Looting and Questions Over Tinubu's Anti-Graft Drive [editorial]
March 31, 2024 | msn.com
TSA: REMITA Was Selected Based On Merit — CBN
March 31, 2024 | msn.com
Uganda out to solve animal feeds puzzle
March 29, 2024 | msn.com
Remita's Choice As Payment Facilitator Merit-Based - CBN
March 27, 2024 | msn.com
Nine out of 31 Cross River MDAs cleared for March salaries – HoS, Eteng
March 26, 2024 | msn.com
22 out of 31 MDAs won’t receive March salaries – C’River Head of Service, Eteng
March 26, 2024 | msn.com
Govt employees to undergo weekly physical exercises
March 22, 2024 | msn.com
MDAs to get incentives to attract health workers – Acting Chief Director
March 22, 2024 | msn.com
NASS oversights promote transparency, accountability in MDAs – Minister
See More Headlines
Receive MDAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MDAS) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/29/2015
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDAS
CUSIP
58404510
CIK
1254419
Web
www.medassets.com
Phone
+1-678-3232500
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover
The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

MDAS Stock Analysis - Frequently Asked Questions

How were (MDAS)'s earnings last quarter?

(MDAS) (NASDAQ:MDAS) issued its quarterly earnings data on Wednesday, July, 29th. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.04. The technology company earned $190.40 million during the quarter, compared to analyst estimates of $187.45 million. The company's revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the company posted $0.30 EPS.

What other stocks do shareholders of (MDAS) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MDAS) investors own include CVS Health (CVS), Home Depot (HD), StoneMor (STON), Blackstone (BX), NVIDIA (NVDA), AbbVie (ABBV), Broadcom (AVGO), Cadence Design Systems (CDNS), DexCom (DXCM) and The Goldman Sachs Group (GS).

This page (NASDAQ:MDAS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media